| Literature DB >> 29264998 |
Roberto Gandini1, Stefano Merolla1, Jacopo Scaggiante1, Marco Meloni2, Laura Giurato2, Luigi Uccioli2, Daniel Konda1.
Abstract
PURPOSE: To detail a percutaneous technique for distal plantar venous arterialization in diabetic, end-stage renal disease (ESRD) patients with no-option critical limb ischemia (CLI). TECHNIQUE: After failure of standard intraluminal recanalization attempts, a subintimal approach through the posterior tibial artery (PTA) is begun using a 0.014-inch, 190- or 300-cm-long guidewire supported by a 2-×20-mm, low-profile balloon catheter positioned a short distance behind the narrow "U-shaped" loop in the guidewire. Typically, heavy calcification in the distal tortuous segment of the PTA prevents reentry to the arterial true lumen; however, an entry in the distal lateral or medial plantar vein from a subintimal channel in the plantar artery can be intentionally pursued as a bailout technique, pointing the tip of the guidewire opposite to the arterial wall calcifications. Venous access is confirmed by contrast injection through the balloon catheter. Once the guidewire is advanced in the distal lateral or medial plantar vein and a plantar arteriovenous fistula (AVF) has been created, the AV anastomosis and the occluded PTA segment are dilated with 0.014-inch balloon catheters. The technique has been attempted in 9 consecutive diabetic, ESRD patients (mean age 69 years; 5 men) with no-option CLI; an AVF was created between the PTA and plantar vein in 7 patients. The mean TcPO2 at 1 month was 30±17 mm Hg (vs 7.3±2.2 at baseline). Six ulcers healed over an average of 21±4 weeks. Three of the 9 patients had below-knee amputations.Entities:
Keywords: arteriovenous fistula; below-the-ankle revascularization; critical limb ischemia; desert foot; ischemic ulcer; limb salvage; no-option CLI; occlusion; plantar vein; posterior tibial artery; subintimal recanalization; vein arterialization
Mesh:
Year: 2017 PMID: 29264998 DOI: 10.1177/1526602817750211
Source DB: PubMed Journal: J Endovasc Ther ISSN: 1526-6028 Impact factor: 3.487